The High Stakes of Player Options in MLB
As the MLB season nears its conclusion, the spotlight turns to certain players grappling with pivotal career choices: stay with their current teams or test the waters of free agency. These decisions hinge on contract clauses known variously as player options or opt-outs. Regardless of terminology, the essence remains consistent—it's the players who ultimately hold the power in this scenario.
Just last April, MLB Trade Rumors highlighted a intriguing list of 13 players facing a crucial crossroad by season's end. Since then, their performances have unfolded, leaving some poised to leverage their options while others may rethink their choices.
One player under scrutiny is
José Berríos (33), who can walk away from the remaining two years and $48 million on his deal. Early in the season, thoughts of opting out were dim; Berríos battled a declining strikeout rate and presented himself more as a reliable innings eater rather than an ace. However, the narrative shifted dramatically when he faced elbow troubles that culminated in Tommy John surgery, which will sideline him until midway through 2027. At this point, opting out is off the table.
Next, we have
Bo Bichette (29), who has two years and $84 million left but could buy himself out for $5 million. His free agency decision last year led him to a more lucrative contract with the Mets over a longer commitment from the Phillies. Despite making a calculated risk by opting for three years at $126 million with opt-outs, Bichette’s current performance casts doubt on his plans. His dismal .239 batting average across 309 plate appearances with the Mets raises significant concerns, especially since he found himself unexpectedly returning to shortstop—where his defensive metrics haven't helped his cause.
Corbin Burnes (32), able to opt-out of $140 million remaining, is in a similar boat regarding his health. After recovering from Tommy John surgery, Burnes recently suffered a teres major strain, further complicating any chance of improving his standing before the opt-out window closes. With his focus likely shifting to just returning to the mound rather than pursuing a potential opt-out, the path looks tough ahead.
Players like
Kyle Freeland (34) and
Ryan Helsley (32) also face uphill battles as they weigh their options. For Freeland, his need to log 170 innings as part of his player option is an elusive target given his historical inconsistencies, while Helsley's recent injury issues invite concern about his longevity and effectiveness as a closer.
While some players are grappling with potential exits from their contracts, others have more troubling performances to account for.
Tatsuya Imai (29) emerged as an intriguing prospect but has failed to translate his NPB success to MLB in the expected ways, struggling with a 6.43 ERA over nine starts.
With the finish line of the season in sight, these player decisions about opting out will have far-reaching implications—not only for their careers but also for the teams looking to construct their rosters. The decisions made by these players can dramatically shift market dynamics as they seek to maximize their earnings and potential for future contracts. For those in the industry, it's a fascinating interplay of performance, health, and strategy that guides the decisions of these athletes.The 2026 free agency scene has a few noteworthy names with the potential to shift rosters significantly, yet health uncertainties loom large. Michael King’s situation exemplifies this dilemma. Once an emerging ace, King has experienced a series of injuries that nearly derailed his chances for a lucrative contract. Now, at 32, he faces a pivotal decision: choosing to stay within a three-year, $75 million deal, or opting out after this season, banking on a promising future.
King's stint in 2023 was impressive; after being elevated to the rotation, he compiled an enviable 2.72 ERA over nearly 270 innings. Despite not being as dominant in 2026, a 3.46 ERA and a slightly diminished strikeout rate may keep him under consideration, especially due to an uptick in velocity. He remains a respectable proposition, earning a spot at fourth in the latest MLBTR Free Agent Power Rankings. Still, if you're tracking his trajectory, the next few months will be crucial.
Then there's Yuki Matsui, who, at 31, has seen more ups and downs. Initially a reliable reliever for the Padres, Matsui's potential becomes more promising as he transitions back from injury with stellar early-season numbers, although a sprinkle of luck is evident in his low ERA and high strand rate. His opt-out after two years at $13.5 million offers a chance for improvement, but whether he can replicate this success will determine his market value.
Emilio Pagán's return to form has been less evident, battling inconsistencies and a dismal strikeout rate that has dropped sharply from past seasons. At 36, his $10 million player option might be a straightforward decision given his lack of current momentum. Meanwhile, Wandy Peralta and Nick Pivetta both confront similar crossroads, and though Peralta has seen a remarkable year, underlying metrics suggest he may be riding a wave of luck rather than skill. Pivetta’s injury status complicates the possibility of opting out of a $32 million deal allowing the Padres to bank on recovery and performance when that time comes.
Finally, Luis Severino sits in a complicated position. The 33-year-old has shown flashes of being serviceable with the Athletics, but injuries threaten his financial future. His $22 million option is a big risk, especially in a minor league setting where his numbers fluctuate noticeably.
As these players weigh their options, their decisions could reshape the free agent market significantly. For those in the industry, it’s more essential than ever to keep an eye on how performance, luck, and health will interplay in shaping their futures. Each choice they make could shift not just their careers, but the competitive landscape of baseball for years to come.
